Professor Nilsson is currently involved in multiple research projects, all aimed to conduct extensive cellular, molecular and functional analyses of blood stem cells, their progeny and their bone marrow microenvironment.

Authors
Title
Published In

Domingues MJ, Nilsson SK, Cao B.

New agents in HSC mobilization.

Int J Hematol. 2017 Feb;105(2):141-152. doi: 10.1007/s12185-016-2156-2. Epub 2016 Nov 30.

Sheikh BN, Yang Y, Schreuder J, Nilsson SK, Bilardi R, Carotta S, McRae HM, Metcalf D, Voss AK, Thomas T.

MOZ (KAT6A) is essential for the maintenance of classically defined adult hematopoietic stem cells.

Blood. 2016 Nov 10;128(19):2307-2318. doi: 10.1182/blood-2015-10-676072. Epub 2016 Sep 23.

Ng ES, Azzola L, Bruveris FF, Calvanese V, Phipson B, Vlahos K, Hirst C, Jokubaitis VJ, Yu QC, Maksimovic J, Liebscher S, Januar V,  Zhang Z, Williams B, Conscience A, Durnall J, Jackson S, Costa M, Elliott D, Haylock DN, Nilsson SK,Saffery R, Schenke-Layland K, Oshlack A, Mikkola HKA, Stanley EG, Elefanty AG.

Differentiation of Human Embryonic Stem Cells to HOXA+ Hemogenic Vasculature That Resembles the Aorta-Gonad-Mesonephros.

Nat Biotechnol. 

Le Texier L, Lineburg KE, Cao B, McDonald-Hyman C, Leveque-El Mouttie L, Nicholls J, Melino M, Nalkurthi BC, Alexander KA, Teal B, Blake SJ, Souza-Fonseca-Guimaraes F, Engwerda CR, Kuns RD, Lane SW, Teng M, Teh C, Gray D, Clouston AD, Nilsson SK, Blazar BR, Hill GR, MacDonald KP.

Autophagy-dependent regulatory T cells are critical for the control of graft-versus-host disease.

JCI Insight. 2016 Sep 22;1(15):e86850.

Griffiths K, Pfleger KDG, Dolezal O, Cao B, Nilsson SK, Pow A, Kvansakul M, Roche M, Perugini M, Dogovski C, Dorflinger M, Zhang Y, Gorry P, Lim K, Lu B, Chang D, Viduka K, Murray-Rust T, Parisi K, Casey J, Nuttall S, Foley M.

I-bodies: human single domain antibodies that selectively antagonize chemokine receptor CXCR4.

J Biol Chem. 2016 Jun 10;291(24):12641-57. doi: 10.1074/jbc.M116.721050. Epub 2016 Apr 1.

Cao B, Zhang Z, Grassinger J, Williams B, Heazlewood CK, Churches QI, James SA, Li S, Papayannopoulou T, Nilsson SK.

Therapeutic targeting and rapid mobilization of endosteal HSC using a small molecule integrin antagonist.

Nat Commun. 2016 Mar 15;7:11007. doi: 10.1038/ncomms11007.

Chalmers BA, Xing H, Houston S, Clark C, Ghassabian S, Kuo A, Cao B, Reitsma A, Murray CE, Stok JE, Boyle GM, Pierce CJ, Littler SW,Winkler DA, Bernhardt PV, Pasay C, De Voss JJ, McCarthy J, Parsons PG, Walter GH, Smith MT, Cooper HM, Nilsson SK, Tsanaktsidis J,Savage GP, Williams CM.

Validating Eaton's Hypothesis: Cubane as a Benzene Bioisostere.

Angew Chem Int Ed Engl. 2016 Mar 7;55(11):3580-5. doi: 10.1002/anie.201510675. Epub 2016 Feb 5.

Cao H, Cardozo D, Nigro J, Oteiza A, Nilsson SK.

The role of CD44 in hemopoietic stem cell regulation during ontogeny.

Haematologica 2015 Jan 101: 26-37; Doi:10.3324/haematol.2015.135921

Storan MJ, Heazlewood SY, Heazlewood CK, Haylock DN, Neaves RJ, Alexander WS, Oteiza A, Nilsson SK.

Megakaryocytes release factors required to thrombin cleave osteopontin, allowing for the negative regulation of hemopoietic stem cells.

Stem Cells. 2015 Jul;33(7):2351-7. doi: 10.1002/stem.2038. Epub 2015 May 15.

Cao B, Hutt OE, Zhang Z, Li S, Heazlewood SY, Williams B, Smith JA, Haylock Dn, Savage GP, Nilsson SK.

Design, synthesis and binding properties of a fluorescent alpha(9)beta(1)/alpha(4)beta(1) integrin antagonist and its application as an in vivo probe for bone marrow haemopoietic stem cells.

Org Biomol. Chem 2014;12(6):965-978.

Soh CL, Giudice A, Jenny RA, Elliott DA, Hatzistavrou T, Micallef SJ, Kianizad K, Seach N, Zúñiga-Pflücker JC, Chidgey AP, Trounson A, Nilsson SK, Haylock DN, Boyd RL, Elefanty AG, Stanley EG.

FOXN1GFP/w Reporter hESCs Enable Identification of Integrin-β4, HLA-DR and EpCAM as Markers of Human Pluripotent Stem Cell-Derived FOXN1+ Thymic Epithelial Progenitor Cells.

Stem Cell Reports. 2014 May 22;2(6):925-37. doi: 10.1016/j.stemcr.2014.04.009. eCollection 2014.

Cao B, Grassinger J, Williams B, Li S, Savage GP, Haylock DN, Hutt OE, Nilsson SK.

Dual α4β1/α9β1 integrin antagonists preferentially bind and mobilize hemopoietic stem cells from endosteal bone marrow.

Org Biomol Chem. 2014;12:965-978.

Ellis SL, Heazelwood SY, Williams B, Borg J, Reitsma AJ, Heazlewood CK, Chidgey AP, Nilsson SK.

The role of Tenascin C in anchoring lymphoid progenitor cells within their niche.

Exp Hematol. 2013 Dec;41(12):1050-61. doi: 10.1016/j.exphem.2013.09.009. Epub 2013 Sep 29.

Cao H, Nilsson SK.

Understanding the role of the microenvironment during definitive hemopoietic development.

Exp Hematol. 2013 Sep;41(9):761-8. doi: 10.1016/j.exphem.2013.06.005. Epub 2013 Jun 22.

Shen Y, CK Heazlewood, Williams B, Neaves R, Haylock DN, McCourt P, Adams T, Nilsson SK.

Megakaryocytes are a key niche component, regulating hemopoietic stem cell proliferation through cytokine release.

Stem Cell Res. 2013 Sep;11(2):782-92. doi: 10.1016/j.scr.2013.05.007. Epub 2013 May 28.

Grassinger J, Haylock DN, Williams B, Olsen GH, Nilsson SK.

Phenotypically identical Hemopoietic Stem Cells isolated from different regions of bone marrow have different biological potential.

Blood. 2010 Oct 28;116(17):3185-96. doi: 10.1182/blood-2009-12-260703. Epub 2010 Jul 14.

Grassinger J, Haylock DN, Storan M, Haines GO, Williams B, Whitty GA, Vinson A, Be CL, Li S, Sørensen ES, Tam PL, Denhardt DT, Sheppard D, Choong PF, Nilsson SK.

Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins.

Blood. 2009 Jul 2;114(1):49-59. doi: 10.1182/blood-2009-01-197988. Epub 2009 May 5.

Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, Bertoncello I, Bendall LJ, Simmons PJ, Haylock DN.

Osteopontin, a Key Component of the Hematopoietic Stem Cell Niche and Negative Regulator of Primitive Hematopoietic Progenitor Cells.

Blood. 2005 Aug 15;106(4):1232-9. Epub 2005 Apr 21.

Nilsson SK, Haylock DN, Johnston HM, Occhiodoro T, Brown TJ, Simmons PJ.

Hyaluronan is synthesised by primitive hemopoietic cells, participates in their lodgement at the endosteum following transplantation and is involved in the regulation of their proliferation and differentiation in vitro.

Blood. 2003 Feb 1;101(3):856-62. Epub 2002 Sep 12.

Hou Z, Nguyen Q, Frenkel B, Nilsson SK, Milne M, Van Wijnen A, Stein JL, Quesenberry P, Lian JB, Stein GS.

Osteoblast-specific gene expression after transplantation of marrow cells: Implications for skeletal gene therapy.

Proc. Natl. Acad. Sci. USA. 1999;96(13):7294-7299.

Nilsson SK, Dooner MS, Weier H-U, Frenkel B, Lian JB, Stein GS, Quesenberry PJ.

Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice.

J Exp Med. 1999 Feb 15;189(4):729–734.

Begg SK, Pollard JW, Radley JM, Chisholm OT, Stanley ER, Bertoncello I.

Delayed hematopoietic development in the osteopetrotic (op/op) mouse.

J Exp Med. 1993 Jan 1;177(1):237-42.